section 2 hypersensitivity reactions. 1.type i hypersensitivity (anaphylactic type) immediate...

21
Section 2 Section 2 Hypersensitivity Hypersensitivity Reactions Reactions

Upload: randolph-powers

Post on 28-Dec-2015

229 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

Section 2 Section 2 Hypersensitivity Hypersensitivity

ReactionsReactions

Page 2: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

1.1. Type I hypersensitivity Type I hypersensitivity (Anaphylactic type)(Anaphylactic type)

Immediate hypersensitivity reaction, resulting from release of pharmacologically active mediators.

Page 3: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

Slide 7.9

Activation of mast cells in type I hypersensitivity and release of their mediators. ECF, eosinophil chemotactic factor; NCF, neutrophil chemotactic factor; PAF, platelet-activating factor. (From Robbins Basic Pathology ,2003 )

Page 4: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

(2) (2) Tissue reactions: variable in severityTissue reactions: variable in severity

Mildest may be only edema. Reaction is triggered by mast cells, basophils. If inflammatory cells are present, many are eosinophils.

Page 5: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

(3) Diseases

① Urticaria and angioneurotic edema

② Asthma

③ Hay fever

④Insect allergy: serious or fatal anaphylaxis may follow. Edema of larynx, with airway obstruction may occur.

Page 6: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

2. Type II Hypersensitivity

Cytolytic or cytotoxic reactions

(1) Mechanism:(1) Mechanism: ① Complement-dependent reactions

Transfusion reactionsErythroblastosis fetal Autoimmune hemolytic anemiaCertain drug reactions

Page 7: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

②Antibody-dependent cell-mediated cytotoxicit

(ADCC).

May be relevant to:

Graft rejection

The destruction of targets too large to be

phagocytosed, such as parasites or tumor cells.

Page 8: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

③Antibody-mediated cellular dysfunction

Myasthenia gravis: muscle weakness

Graves’ disease:Graves’ disease: hyperthyroidism

Page 9: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

Slide 7.10

Schematic illustration of three different mechanisms of antibody-mediated injury in type hypersensitivity. A, Complement-dependent reactions that Ⅱlead to lysis of cells or render them susceptible to phagocytosis.

(From Robbins Basic Pathology ,2003 )

Page 10: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

Slide 7.11

Antibody-dependent cell-mediated cytotoxicity (ADCC). IgG-coated target cells are killed by cells that bear Fc receptors for IgG (e.g., NK cells,

macrophages). . (From Robbins Basic Pathology ,2003 )

Page 11: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

Slide 7.12

Antireceptor antibodies disturb the normal function of receptors. In this example, acetylcholine receptor antibodies impair neuromuscular transmission

in myasthenia gravis. (From Robbins Basic Pathology ,2003 )

Page 12: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

3. 3. Type Hypersensitivity ⅢType Hypersensitivity Ⅲ(Immune complex-mediated)(Immune complex-mediated)

(1) Reaction types(1) Reaction types

① Arthus reaction

② serum sickness

③ Collagen diseases

Page 13: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

(2) (2) Toxic complex diseases:Toxic complex diseases:

① Acute glomerulonephritis

② Systemic lupus erythematosus

③ Necrotizing angiitides

④ Rheumatoid arthritis

⑤ Progressive systemic sclerosis

⑥ Dermatomyositis etc.

Page 14: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

Slide 7.13

Schematic illustration of the three sequential phases in the induction of systemic type (immune complex) hypersensitivity. Ⅲ(From Robbins Basic Pathology ,2003 )

Page 15: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

Slide 7.14

Schematic representation of the pathogenesis of immune complex-mediated tissue injury. The morphologic consequences are depicted as boxed areas. . (From Robbins Basic Pathology ,2003 )

Page 16: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

Slide 7.15

Immune complex vasculitis. The necrotic vessel wall is replaced by smudgy, pink “fibrinoid” (Dr. Trace Worrell)

(From Robbins Basic Pathology ,2003 )

Page 17: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

4. Type HypersensitivityⅣ

(Cell-Mediated )

Delayed hypersensitivity reaction

(1) TissueTissue reactionreaction: Consist of parenchymal destruction associated with perivascular lymphocytic and macrophage reaction.

Page 18: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

(2) (2) Diseases:Diseases:

① ① Chronic active hepatitisChronic active hepatitis

② ② Viral exanthem(Viral exanthem( 皮疹)皮疹) ③ ③ Contact dermatitisContact dermatitis

④ ④ Graft rejectionGraft rejection

⑤ ⑤ Inflammatory bowel disease. Inflammatory bowel disease.

Page 19: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

Slide 7.16

Delayed hypersensitivity in the skin. Immunoperoxidase staining reveals a predominantly perivascular cellular infiltrate that marks positively with anti-CD4 antibodies. ( Dr. Louis Picker) .

(From Robbins Basic Pathology ,2003 )

Page 20: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

Slide 7.17

A section of a lymph node shows several granulomas, each made up of an aggregate of epithelioid cells and surrounded by lymphocytes. The granuloma in the center shows several multinucleate giant cells. ( Dr. Trace Worrell) (From Robbins Basic Pathology ,2003 )

Page 21: Section 2 Hypersensitivity Reactions. 1.Type I hypersensitivity (Anaphylactic type) Immediate hypersensitivity reaction, resulting from release of pharmacologically

Slide 7.18

Schematic illustration of the events that give rise to the formation of granuloma in type Ⅳhypersensitivity reactions. Note the role played by T cell-derived cytokines. . (From Robbins Basic Pathology ,2003 )